Three Cases of Central Nervous System Infection Caused by Multi-Drug-Resistant Acinetobacter baumannii
Eun-Yeong KIM; Song-Mi MOON; Yeon-Ju KIM; Hyun-Jin PARK; Jun-Seong SON; Mi-Suk LEE.
Korean Journal of Medicine
; : 118-121, 2011.
ArtÃculo en Ko | WPRIM | ID: wpr-30872
Documentos relacionados
Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection.
Clinical Use of Colistin in Biofilm-Associated Infections.
[Concerns of Performance Evaluation on Central Nervous System Infection Pathogen Metagenome Sequencing Reagent].
The definition and global epidemiology of nonmobile colistin resistance (NMCR-3) determinants in Aeromonas from 1968 to 2022.
Polymyxins for CNS infections: Pharmacology and neurotoxicity.
Acinetobacter Infections.
Colistin resistance in carbapenem non-susceptible Acinetobacter baumanii in a tertiary care hospital in India: clinical characteristics, antibiotic susceptibility and molecular characterization.
Ceftazidime-avibactam for the Treatment of Multidrug-resistant Pseudomonas aeruginosa Central Nervous System Infection in Pediatric Patient: A Case Report.
Intraventricular administration of antibiotics by ommaya reservoir for patients with multidrug-resistant <i>Acinetobacter baumannii</i> central nervous system infection.
Central Nervous System Infections in Immunocompromised Patients.